New migraine pill under watch in korea: NURTEC ODT 75 mg tested on 3,000 adults
NCT ID NCT07497854
First seen Apr 19, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study will monitor 3,000 adults in Korea who take NURTEC ODT 75 mg for migraines (with or without aura). The goal is to check for side effects and see how well the medicine works for stopping migraine attacks and preventing future ones. Participants must be 19 or older and follow the approved dosing instructions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITH OR WITHOUT AURA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.